Q3 Earnings Forecast for NRIX Issued By Leerink Partnrs
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – Leerink Partnrs issued their Q3 2025 earnings per share estimates for Nurix Therapeutics in a report issued on Monday, March 17th. Leerink Partnrs analyst F. Khurshid expects that the company will post earnings of ($0.96) per share for the quarter. Leerink Partnrs currently has a “Hold” rating […]
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – Leerink Partnrs issued their Q3 2025 earnings per share estimates for Nurix Therapeutics in a report issued on Monday, March 17th. Leerink Partnrs analyst F. Khurshid expects that the company will post earnings of ($0.96) per share for the quarter. Leerink Partnrs currently has a “Hold” rating […]
